Saturday, November 2, 2024
HomeIndustriesBiotechnology

Biotechnology

Cytovale® Announces Commercial Launch of IntelliSep® Sepsis Test, the First-of-its-Kind Diagnostic Tool for Emergency Departments

Cytovale, a pioneering medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, announced the U.S. commercial launch of...

Etiometry Gains FDA Clearance of AI-Based Algorithm that Alerts Risk of Hypercapnia for Neonates in Critical Care

Etiometry’s IVCO2 Index™ is now available for continuous non-invasive NICU ventilation monitoring for optimal outcomes without additional devices. Etiometry, the leader in clinical decision-support software,...

Quanterix’s Simoa® Technology Powers Large, International Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Neurological Disease Activity in Pediatric Patients

The company’s ultra-sensitive biomarker technology supports milestone achievement in establishing a method for clinicians to identify and interpret elevated values of sNfL in children...

Octave Bioscience Closes $30M Extension to Series B Funding

Octave Bioscience, announced the closing of a $30M extension to its Series B funding round. The round included participation from new strategic investors: Novartis (dRx...

RSNA: Artificial Intelligence Uses Lung CT Data to Predict Mortality Risk

Artificial intelligence (AI) can use data from low-dose CT scans of the lungs to improve risk prediction for death from lung cancer, cardiovascular disease...
0FansLike
0FollowersFollow
spot_img

Hot Topics